Cannabis Components To Be Used In Potential COVID-19 Vaccine
A vaccine component using a cannabis-based protein could be ready as soon as the end of August.
Researchers specializing in infectious disease at the University of Saskatchewan in Canada are turning to cannabis as they build a new COVID-19 virus vaccine candidate. The research team says that a plant-based antigen may be easier to produce commercially on a broad scale than animal-based antigens.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.